Hepatitis, HIV, tuberculosis (TB) and sexually transmitted infections such as syphilis and gonorrhoea continue to pose ...

ViiV’s new daily HIV treatment has been approved in the EU, as the company aims to win ... The two drug “backbone” is used in case the HIV virus resident in the patient’s body develops ...

The EU and other Western governments need to step up their funding commitments to AIDS programmes or risk a reversal of progress on ending HIV as a public health emergency by 2030 — at least those are ...